FindTrial
Sign In

Understanding Genetic Screening in Family-Related Gynecological Cancers

Genetic Screening in Familial Gynaecological Cancers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102387
Enrollment
150
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C579- Malignant neoplasm of female genital organ, unspecified Health Condition 2: C569- Malignant neoplasm of unspecifiedovary Health Condition 3: C55- Malignant neoplasm of uterus, partunspecified

Interventions

Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women above the age of 18 years, diagnosed with ovarian or endometrial cancer. Individuals with a strong family history of gynecologic cancers.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women. Individuals with severe psychiatric conditions.

Design outcomes

Primary

MeasureTime frame
Knowing the gene mutation will direct the cancer treatment for you. It will also help in identifying other family members at risk and help them consider risk reducing measures.Timepoint: 6 weeks & 8 weeks—

Secondary

MeasureTime frame
Acceptance rate of genetic screening. Percentage of positive & negative genetic tests. Psychological impact & decision regret. Compliance with preventive measures.Timepoint: 1 year & 2 year—

Countries

India

Contacts

Public ContactAvisha Malu

Kasturba Medical College Manipal MAHE Manipal

shyamala.g@manipal.edu9424578444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026